Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety of ASP8232 in Subjects With Renal Impairment and in Type 2 Diabetes Mellitus Subjects With Chronic Kidney Disease [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating the pharmacokinetics, pharmacodynamics, and safety of ASP8232 in subjects with chronic kidney disease and in type 2 diabe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• ASP8232 (ASP8232)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Healthy Subjects, Pharmacokinetics of ASP8232 | Phase 1, Phase 2 | Status: COMPLETED